CASAMENTI, FIORELLA
 Distribuzione geografica
Continente #
NA - Nord America 8.407
EU - Europa 5.785
AS - Asia 1.112
OC - Oceania 92
AF - Africa 47
SA - Sud America 34
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.482
Nazione #
US - Stati Uniti d'America 8.393
RU - Federazione Russa 1.695
PL - Polonia 1.676
IE - Irlanda 558
SE - Svezia 552
IT - Italia 446
SG - Singapore 372
HK - Hong Kong 273
UA - Ucraina 257
DE - Germania 232
CN - Cina 174
FI - Finlandia 153
AU - Australia 92
IN - India 87
GB - Regno Unito 77
JO - Giordania 64
TR - Turchia 52
CH - Svizzera 37
VN - Vietnam 33
CI - Costa d'Avorio 30
FR - Francia 29
BR - Brasile 26
ID - Indonesia 20
BE - Belgio 19
ES - Italia 14
NL - Olanda 14
SC - Seychelles 13
CA - Canada 12
PT - Portogallo 8
AZ - Azerbaigian 6
JP - Giappone 6
LT - Lituania 6
EU - Europa 5
KR - Corea 5
RO - Romania 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
BG - Bulgaria 2
BO - Bolivia 2
EC - Ecuador 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MU - Mauritius 2
PE - Perù 2
UZ - Uzbekistan 2
BS - Bahamas 1
BY - Bielorussia 1
CL - Cile 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
LV - Lettonia 1
MX - Messico 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 15.482
Città #
Santa Clara 2.087
Warsaw 1.674
Fairfield 932
Chandler 646
Dublin 558
Jacksonville 477
Ashburn 422
Woodbridge 413
Cambridge 353
Seattle 328
Wilmington 305
Houston 298
Singapore 294
Ann Arbor 185
Princeton 156
Hong Kong 150
Florence 114
Boardman 111
Boston 94
Melbourne 91
Beijing 85
Medford 84
Altamura 81
Mumbai 78
Lawrence 76
Buffalo 66
San Diego 49
Izmir 43
Bern 36
New York 36
Shanghai 34
Norwalk 33
Abidjan 30
Falls Church 29
Moscow 27
Dong Ket 26
Dearborn 25
Bremen 24
Hillsboro 22
Brussels 19
Jakarta 19
Milan 19
Rome 19
Auburn Hills 13
Helsinki 13
Kent 13
Los Angeles 12
West Jordan 12
Yubileyny 11
Andover 10
Frankfurt Am Main 9
Phoenix 9
Tappahannock 9
Toronto 9
Toulouse 9
Barcelona 8
Verona 8
Santa Maria A Monte 7
Baku 6
Laurel 6
Salerno 6
Usingen 6
Guangzhou 5
Ankara 4
Bradford 4
Chieti 4
London 4
Nanjing 4
Redmond 4
Rimini 4
Brescia 3
Bursa 3
Evora 3
Frankfurt am Main 3
Kasugai 3
Lisbon 3
Naaldwijk 3
Paliano 3
Redwood City 3
San Mateo 3
Valencia 3
Almaty 2
Amsterdam 2
Arezzo 2
Arnsberg 2
Asti 2
Bari 2
Bishkek 2
Castelliri 2
Chaville 2
Colombo 2
Council Bluffs 2
Dhaka 2
Fuzhou 2
Hangzhou 2
Hefei 2
Jinan 2
La Paz 2
Lima 2
Maletto 2
Totale 10.928
Nome #
Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: A mechanistic insight 288
Oleuropein Aglycone: A Possible Drug against Degenerative Conditions. In Vivo Evidence of its Effectiveness against Alzheimer's Disease 286
The polyphenol oleuropein aglycone protects TgCRND8 mice against Aß plaque pathology 276
Oleuropein aglycone protects against pyroglutamylated-3 amyloid-ß toxicity: biochemical, epigenetic and functional correlates 270
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8 264
Lithium Improves Hippocampal Neurogenesis,Neuropathology and Cognitive Functions in APP MutantMice 262
Young human cholinergic neurons respond to physiological regulators and improve cognitive symptoms in an animal model of Alzheimer’s disease 248
The Brain Cholinergic System in Neurodegenerative Diseases 238
Employing AD animal models for translational research: focus on dietary components 236
Neurodegeneration and the cholinergic system 217
Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation. 205
Farmaci per le malattie neurodegenerative 190
The polyphenol oleuropein aglycone modulates the PARP1-SIRT1 interplay: an in vitro and in vivo study 189
Different Patterns of Neurodegeneration and Glia Activation in CA1 and CA3 Hippocampal Regions of TgCRND8 Mice 176
Successful Brain Delivery of Andrographolide Loaded in Human Albumin Nanoparticles to TgCRND8 Mice, an Alzheimer’s Disease Mouse Model 169
A New Kid on the Block? Carbonic Anhydrases as Possible New Targets in Alzheimer's Disease 159
Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease. 149
STEREOSELECTIVE INCREASE IN CHOLINERGIC TRANSMISSION BY R-(+)- HYOSCYAMINE 145
Olive oil polyphenols can be useful to prevent aging-associated neurodegeneration 143
Abnormal processing of tau in the brain of aged TgCRND8 mice 142
Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease 137
Development of Blood-Brain Barrier Permeable Nanoparticles as Potential Carriers for Salvianolic Acid B to CNS 137
Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice 136
Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease. 136
Long-term neuro-glial co-cultures as a brain aging model: hallmarks of senescence, miRNA expression profiles and comparison with in vivo models 132
ARE THE NEUROCHEMICAL AND BEHAVIORAL CHANGES INDUCED BY LESIONS OF THE NUCLEUS BASALIS IN THE RAT A MODEL OF ALZHEIMER'S DISEASE? 132
Changes in cortical acetylcholine output induced by modulation of the nucleus basalis. 132
A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells 132
C-fos expression in the rat nucleus basalis upon excitotoxic lesion with quisqualic acid: a study in adult and aged animals 129
Inhibition of acetylcholine-induced activation of extracellular regulated protein kinase prevents the encoding of an inhibitory avoidance response in the rat 127
Oleuropein aglycone and polyphenols from olive mill waste water ameliorate cognitive deficits and neuropathology 127
The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo. 126
Olive polyphenols: new promising agents to combat aging-associated neurodegeneration 126
Extracellular chaperones prevent Aβ42-induced toxicity in rat brains 125
Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N 125
Lesions of cholinergic forebrain nuclei: changes in avoidance behavior and scopolamine actions. 123
BRAIN-TARGETED DELIVERY OF ANDROGRAPHOLIDE USING SOLID LIPID NANOPARTICLES: IN VITRO AND IN VIVO EVALUATION 123
Novel S-acyl glutathione derivatives prevent amyloid oxidative stress and cholinergic dysfunction in Alzheimer disease models. Free Radic Biol Med. 122
Poly(ethyl cyanoacrylate) nanoparticles for brain delivery of andrographolide 122
Postnatal development of functional properties of visual cortical cells in rats with excitotoxic lesions of basal forebrain cholinergic neurons. 121
Aβ plaque-associated glial reaction as a determinant of apoptotic neuronal death and cortical gliogenesis: a study in APP mutant mice 120
Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: implication in Alzheimer's disease. 120
Oleuropein aglycone counteracts Aβ42 toxicity in the rat brain 119
Nerve growth factor increases extracellular acetylcholine levels in the parietal cortex and hippocampus of aged rats and restores object recognition. 118
Neutrophils CD11b and fibroblasts PGE2 are elevated in Alzheimer's disease 117
Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. 117
Effect of phosphatidylserine on acetylcholine output from the cerebral cortex of the rat. 116
Acetylcholine release from fetal tissue homotopically grafted to the motoneuron-depleted lumbar spinal cord. An in vivo microdialysis study in the awake rat. 116
Long-term ethanol consumption by rats: effect on acetylcholine release in vivo, choline acetyltransferase activity, and behavior. 115
Effects of 4-aminopyridine on acetylcholine output from the cerebral cortex of the rat in vivo. 114
An analysis of cholecystokinin-induced increase in acetylcholine output from cerebral cortex of the rat. 114
Activation of brain cholinergic system by noncholinomimetic agents 114
Cholinergic dysfunction, neuronal damage and axonal loss in TGCRND8 mice. 114
The release of endogenous GABA and glutamate from the cerebral cortex in the rat. 113
The brain cholinergic system as a target of cognition enhancers 113
Effect of nerve growth factor and GM1 ganglioside on the recovery of cholinergic neurons after a lesion of the nucleus basalis in aging rats 110
Changes in presynaptic proteins, SNAP-25 and synaptophysin, in the hippocampal CA1 area in ischemic gerbils. 109
Acetylcholine release in freely moving rats by means of transversal dialysis coupled to an HPLC with electrochemical detection 109
Prefibrillar amyloid aggregates could be generic toxins in higher organisms 109
Effects of ganglioside treatment in rats with a lesion of the cholinergic forebrain nuclei. 108
Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats. 107
Aging of brain cholinergic neurons: pharmacological interventions. 105
Combined treatment with atorvastatin and minocycline suppresses severity of EAE 104
Unilateral and bilateral nucleus basalis lesions: differences in neurochemical and behavioural recovery. 104
Employing AD animal models for effective translational research 103
Rivastigmine antagonises deficits in prepulse inhibition induced by selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis 102
Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis. 102
NO-flurbiprofen attenuates excitotoxin-induced brain inflammation, and releases nitric oxide in the brain 101
Hyperphosphorylation and deposition of tau in the brain of a human APP transgenic mouse model 101
Immunogenicity and therapeutic efficacy of phage-displayed beta-amyloid epitopes 100
Effect of BM-5, a presynaptic antagonist-postsynaptic agonist, on cortical acetylcholine release. 100
The brain cholinergic system in ageing mammals. 100
Selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis impairs prepulse inhibition of acoustic startle. 99
Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats. 99
Acetylcholine output from the cerebral cortex, choline uptake and muscarinic receptors in morphine dependent freely-moving rats. 98
Garcinoic acid prevents β-amyloid (Aβ) deposition in the mouse brain 97
Enhanced acetylcholine release in the hippocampus and cortex during acquisition of an operant behavior 96
Oleuropein aglycon relieves memory impairments, induces brain autophagy and reduces Aß load in the TgCRND8 mouse model of Alzheimer’s Disease 93
Amyloid ß-peptides injection into the cholinergic nuclei: Morphological, neurochemical and behavioral effects 91
Interaction between nerve growth factor and GM1 monosialoganglioside in preventing cortical choline acetyltransferase and high affinity choline uptake decrease after lesion of the nucleus basalis. 91
Recovery of cortical acetylcholine output after ganglioside treatment in rats with lesion of the nucleus basalis. 91
NGF treatment potentiates c-fos expression in the rat nucleus basalis upon excitotoxic lesion with quisqualic acid 91
Induction of inflammatory mediators and microglial activation in mice transgenic for human P301S tau protein 91
Decrease of acetylcholine release from cortical slices in aged rats: investigations into its reversal by phosphatidylserine. 90
The validity of animal models in the search for drugs for the aging brain. 88
Comparison between flurbiprofen and its nitric oxide-releasing derivatives HCT-1026 and NCX-2216 on Abeta(1-42)-induced brain inflammation and neuronal damage in the rat 88
Adult hippocampal neurogenesis and cortical gliogenesis in APP mutant mice 88
Cellular acetylcholine content and neuronal differentiation 87
Phosphatidylserine reverses the age-dependent decrease in cortical acetylcholine release: a microdialysis study. 87
Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway 87
A nutrigenomics approach for the study of anti-aging interventions: olive oil phenols and the modulation of microRNA profiles in mouse brain 87
Effects of novelty and pain on behavior and hippocampal extracellular ACh levels in male and female rats. 85
Activation of the p38MAPK pathway cascade in models of neurodegenerative diseases in the rat in vivo 83
Activation of MAPK pathways in the brain of TgCRND8 mice 83
Inhibition of GSK-3β by lithium improves amyloid pathology and learning and memory functions in a human APP transgenic mouse model 83
Albumin Nanoparticles for Brain Delivery: A Comparison of Chemical versus Thermal Methods and invivo Behavior 82
Local cerebral glucose utilization following unilateral and bilateral lesions of the nucleus basalis magnocellularis in the rat. 82
Administration of amyloid ß-peptides into the medial septum of rats decreases acetylcholine release from hippocampus "in vivo" 80
Acetylcholine and amino acid neurotransmitters in epidural cups of freely moving rats: effect of acute and chronic treatment with antischizophrenic drugs. 79
Oleuropein aglycon relieves memory impairments, induces brain autophagy and reduces Aß load in the TgCRND8 mouse model of Alzheimer’s Disease 79
Totale 12.811
Categoria #
all - tutte 39.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.806


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020952 0 0 0 0 0 0 0 323 224 134 232 39
2020/20211.708 159 126 133 153 51 205 96 162 126 274 95 128
2021/2022939 22 104 49 40 53 54 35 43 51 42 189 257
2022/20232.447 251 296 125 208 221 480 329 125 267 6 79 60
2023/2024742 47 120 154 42 52 83 29 140 7 23 23 22
2024/20254.982 208 627 397 972 1.863 758 72 85 0 0 0 0
Totale 15.620